{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T04:29:06Z","timestamp":1768883346125,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.ahj.2008.07.005","type":"journal-article","created":{"date-parts":[[2008,9,27]],"date-time":"2008-09-27T04:39:55Z","timestamp":1222490395000},"page":"751.e1-751.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Systemic exposure of everolimus after stent implantation: A pharmacokinetic study"],"prefix":"10.1016","volume":"156","author":[{"given":"Marcus","family":"Wiemer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok","family":"Seth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Neuzner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert","family":"Richardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan J.","family":"Piek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Desaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Macaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis J.","family":"Bol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine","family":"Miquel-Hebert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolien","family":"De Roeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick W.","family":"Serruys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2008.07.005_bib1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1056\/NEJMra051091","article-title":"Coronary-artery stents","volume":"354","author":"Serruys","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2008.07.005_bib2","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/CIRCULATIONAHA.106.666800","article-title":"A cause of concern","volume":"115","author":"Camenzind","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.07.005_bib3","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","article-title":"Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study","volume":"369","author":"Daemen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2008.07.005_bib4","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1093\/eurheartj\/ehl282","article-title":"Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a metaanalysis","volume":"27","author":"Nordmann","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2008.07.005_bib5","first-page":"32","article-title":"Sirolimus PK Trial: a pharmacokinetic study of the sirolimus-eluting BX Velocity stent in patients with de novo coronary lesions","volume":"67","author":"Vetrovec","year":"2006","journal-title":"Cath Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2008.07.005_bib6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2165\/00003495-200464080-00005","article-title":"Everolimus","volume":"64","author":"Chapman","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.ahj.2008.07.005_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.amjcard.2004.08.074","article-title":"Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial)","volume":"95","author":"Costa","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2008.07.005_bib8","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/01.CIR.0000128850.84227.FD","article-title":"Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer","volume":"109","author":"Grube","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.07.005_bib9","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.amjcard.2006.02.054","article-title":"Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials)","volume":"98","author":"Tsuchiya","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2008.07.005_bib10","series-title":"FUTURE II: multicenter evaluation of the bioabsorbable polymer-based everolimus-eluting stent TCT 2003","author":"Grube","year":"2003"},{"key":"10.1016\/j.ahj.2008.07.005_bib11","first-page":"58","article-title":"A randomized comparison of a durable polymer everolimus-eluting stent with a bare metal coronary stent: the SPIRIT first trial","volume":"1","author":"Serruys","year":"2005","journal-title":"Euro Intervention"},{"key":"10.1016\/j.ahj.2008.07.005_bib12","first-page":"266","article-title":"One-year results of a durable polymer everolimus-eluting stent in de novo coronary narrowings (The SPIRIT FIRST Trial)","volume":"1","author":"Tsuchida","year":"2005","journal-title":"Euro Intervention"},{"key":"10.1016\/j.ahj.2008.07.005_bib13","first-page":"286","article-title":"Randomized comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trial","volume":"2","author":"Serruys","year":"2006","journal-title":"Euro Intervention"},{"key":"10.1016\/j.ahj.2008.07.005_bib14","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S1053-2498(02)01221-4","article-title":"Everolimus in de novo cardiac transplantation: pharmacokinetics, therapeutic range, and influence on cyclosporine exposure","volume":"22","author":"Kovarik","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ahj.2008.07.005_bib15","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1046\/j.1600-6143.2004.00601.x","article-title":"Therapeutic drug monitoring for everolimus in heart transplant recipients based on exposure-effect modeling","volume":"4","author":"Starling","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ahj.2008.07.005_bib16","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/00007890-200203270-00016","article-title":"Exposure-response relationships for everolimus in de novo kidney transplantation: defining a therapeutic range","volume":"73","author":"Kovarik","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.ahj.2008.07.005_bib17","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.healun.2005.12.001","article-title":"Everolimus in pulmonary transplantation: pharmacokinetics and exposure-response relationships","volume":"25","author":"Kovarik","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ahj.2008.07.005_bib18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jchromb.2004.11.016","article-title":"High-performance liquid chromatography with ultraviolet detection for therapeutic drug monitoring of everolimus","volume":"816","author":"Baldelli","year":"2005","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.ahj.2008.07.005_bib19","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/01.ftd.0000175911.70172.2e","article-title":"The role of therapeutic monitoring of everolimus in solid organ transplantation","volume":"27","author":"Mabasa","year":"2005","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.ahj.2008.07.005_bib20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00007691-200410000-00007","article-title":"Everolimus therapeutic concentration range defined from a prospective trial with reduced-exposure cyclosporine in de novo kidney transplantation","volume":"26","author":"Kovarik","year":"2004","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.ahj.2008.07.005_bib21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00007890-199707150-00008","article-title":"SDZ RAD, a new rapamycin derivate: pharmacological properties in vitro and in vivo","volume":"64","author":"Schuler","year":"1997","journal-title":"Transplantation"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287030800570X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287030800570X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:37:28Z","timestamp":1757569048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000287030800570X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S000287030800570X"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2008.07.005","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic exposure of everolimus after stent implantation: A pharmacokinetic study","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2008.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}